Peter Ostrup Jensen
Overview
Explore the profile of Peter Ostrup Jensen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
4622
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arleth T, Baekgaard J, Dinesen F, Creutzburg A, Dalsten H, Queitsch C, et al.
Free Radic Biol Med
. 2025 Feb;
230:309-319.
PMID: 39956475
Introduction: A liberal supplemental oxygen approach is recommended for all severely injured trauma patients despite limited evidence. Liberal oxygen administration may cause oxidative stress. The aim of this study was...
2.
3.
Danielsen A, Massarenti L, Minculescu L, Jensen P, Hansen P, Holmstrup P, et al.
J Periodontal Res
. 2024 Jul;
60(2):177-188.
PMID: 38962877
Aim: Periodontitis is an inflammatory disease driven by opportunistic bacteria including Porphyromonas gingivalis and Fusobacterium nucleatum, where T-cell and NKT-cell responses to these bacteria in patients with periodontitis grade B...
4.
Massarenti L, Nielsen C, Danielsen A, Jensen P, Enevold C, Damgaard C
J Periodontol
. 2024 Jun;
96(2):119-128.
PMID: 38884611
Background: Increasing evidence indicates that periodontitis contributes to systemic low-grade inflammation. Porphyromonas gingivalis is strongly associated with periodontitis, and antibodies against the bacterium may be used as a serological proxy...
5.
Jensen P, Olsen P, Matovu Dungu A, Egelund G, Jensen A, Ravn P, et al.
APMIS
. 2024 Jan;
132(12):1078-1085.
PMID: 38284501
Bacterial aerobic respiration may determine the outcome of antibiotic treatment in experimental settings, but the clinical relevance of bacterial aerobic respiration for the outcome of antibiotic treatment has not been...
6.
Katzenstein T, Faurholt-Jepsen D, Qvist T, Jensen P, Pressler T, Krogh Johansen H, et al.
APMIS
. 2023 Jun;
131(8):419-425.
PMID: 37294911
Ceftolozane-tazobactam is a new β-lactam/β-lactamase inhibitor combination approved by the U.S. Food and Drug Administration in 2019 for the treatment of hospital-acquired and ventilator-associated pneumonia. The combination is a particularly...
7.
Jensen P, Rikvold P, Larsen K, Jorgensen M, Kragelund C
Int J Dent
. 2023 May;
2023:1308326.
PMID: 37152477
Aim: There is need of an objective "standard procedure" that is reliable and clinically applicable for estimating oral neutrophil content in relation to oral diseases. Methods: Forty-one patients with suspected...
8.
Adams Y, Clausen A, Jensen P, Lager M, Wilhelmsson P, Henningson A, et al.
iScience
. 2023 Jan;
26(1):105838.
PMID: 36686395
Lyme neuroborreliosis (LNB), a tick-borne infection caused by spirochetes within the sensu lato (s.L.) complex, is among the most prevalent bacterial central nervous system (CNS) infections in Europe and the...
9.
Laulund A, Schwartz F, Christophersen L, Kolpen M, Jensen P, Calum H, et al.
Biofilm
. 2023 Jan;
5:100100.
PMID: 36660364
Introduction: Chronic wounds have a compromised microcirculation which leads to restricted gas exchange. The majority of these hypoxic wounds is infested with microorganisms congregating in biofilms which further hinders the...
10.
Thomsen K, Hoiby N, Jensen P, Ciofu O, Moser C
Biomedicines
. 2022 Sep;
10(9).
PMID: 36140163
Biofilm infections are tolerant to the host responses and recalcitrance to antibiotic drugs and disinfectants. The induced host-specific innate and adaptive immune responses by established biofilms are significantly implicated and...